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OBJECTIVES The purpose of this study was to investigate the relationship between arterial and coronary
sinus endothelin (ET) concentrations and coronary vasomotor responses during rapid atrial
pacing in patients with chest pain and normal coronary arteriograms (CPNA).
BACKGROUND Plasma ET concentrations are significantly higher in CPNA patients than in healthy control
subjects.
METHODS We investigated 19 carefully characterized CPNA patients (14 women; mean age 53 6 9
years) of whom 10 had positive electrocardiographic responses to exercise. The percentage fall
in coronary vascular resistance (%d.CVR) after 10 min of rapid atrial pacing was determined
using a thermodilution pacing catheter. Plasma ET concentrations were measured by
radioimmunoassay on simultaneously drawn arterial and coronary sinus samples.
RESULTS No significant differences in ET concentrations were observed between men and women, but
a strong statistical trend suggested that %d.CVR was lower in women than men (27[23 to
31]% vs. 34[29 to 45]%—median[interquartile range]; p 5 0.07). Simple regression analysis
including only the women (n 5 14) suggested a significant relationship between baseline
arterial ET concentrations and %d.CVR (R2 5 0.34; p 5 0.06). Furthermore, stepwise
multivariate regression analysis of the group as a whole indicated that both gender (p 5 0.03)
and baseline arterial ET concentration (p 5 0.02) were independently predictive of %d.CVR
(R2 5 0.44; overall p 5 0.02); this relationship predicts that women with high ET levels
would have the lowest %d.CVR during pacing.
CONCLUSIONS These data support the hypothesis that elevated ET activity may be associated with reduced
coronary flow responses during rapid atrial pacing in CPNA patients. (J Am Coll Cardiol
1999;34:455–60) © 1999 by the American College of Cardiology
Coronary microvascular dysfunction can be demonstrated in
a proportion of patients with chest pain and normal coro-
nary arteriograms (CPNA) (1). The pathogenesis of such
microvascular dysfunction remains poorly understood, but
previous studies (2–5) have demonstrated evidence of cor-
onary endothelial dysfunction. Endothelin (ET) is a potent
vasoconstrictor peptide produced by vascular endothelium
which appears to play an important role in cardiovascular
regulation and pathophysiology (6 – 8). Recent studies
(9,10) have indicated that peripheral immunoreactive ET
concentrations are elevated in CPNA patients (in particular,
those with positive exercise electrocardiogram [eECG], left
bundle branch block or a history of myocardial infarction)
compared with healthy control subjects (10). Most recently,
Newby et al. (11) have demonstrated reduced sensitivity of
peripheral resistance vessels to exogenous ET in CPNA
patients with positive eECG compared with healthy age-
and gender-matched control subjects. They concluded that
their findings were consistent with increased ET production
and down-regulation of the ETA receptor. A preliminary
report by Huelmos et al. (12) has also recently described an
inverse correlation between scintigraphically determined
myocardial perfusion reserve and plasma ET levels in a
group of patients with cardiovascular risk factors. These
data support the hypothesis that elevated ET levels may
have pathophysiologic significance in the CPNA patient
group. In this article, we report for the first time a study
examining the relationship between arterial and coronary
sinus ET levels and coronary sinus blood flow responses
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during rapid atrial pacing in a group of carefully character-
ized CPNA patients.
METHODS
Patients. We studied 19 patients (14 women) with chest
pain and completely normal coronary arteriograms. All
patients had typical exertional angina, and none gave a
history suggesting coronary vasospasm (pain occurring pri-
marily at rest, preserved exercise tolerance and/or episodes
of pain associated with acute ST segment elevation). Hy-
perventilation testing (13) was also negative in all cases. No
significant valvular abnormality or left ventricular dysfunc-
tion was detected by echocardiography in any of the study
patients. None of the patients had a history of hypertension
or concomitant metabolic abnormalities. Ischemic ST seg-
ment changes (.0.1 mV depression at 80 ms after the J
point) during bicycle eECG were present in 10 of the 19
study patients.
Invasive assessment. The study was approved by the Local
Research Ethics Committee, and all patients provided fully
informed consent before participation. Antianginal medica-
tion, except for sublingual nitroglycerin, was stopped one
week before invasive assessment. No sedative or analgesic
medications other than local analgesic (lidocaine) were
administered before invasive assessment. After an overnight
fast, a 7-F Wilton-Webster thermodilution pacing catheter
(Webster Labs., Baldwin Park, California) was advanced
from the left antecubital vein to a midposition in the
coronary sinus. Coronary sinus blood flow (CSBF) mea-
surements were performed by continuous infusion of cold
saline solution (36 ml/min) for 20 to 25 s. A Teflon catheter
for arterial blood sampling and pressure measurements was
also inserted into the distal aorta via the femoral artery. The
catheters were kept patent by intermittent infusion of
sodium chloride solution (154 mmol/liter), to which a
maximum of 300 IU of heparin was added. Electrocardio-
graphic monitoring was performed continuously during the
procedure.
After an equilibration period of 15 min, baseline arterial
and coronary sinus blood samples were drawn in triplicate
with simultaneous measurements of hemodynamic variables
(heart rate, blood pressure and CSBF). Atrial pacing was
then performed at a constant rate of 150 beats/min for a
period of 10 min. Intravenous atropine (0.25 mg) was given
just before pacing to prevent pacing-induced atrioventricu-
lar block. During the last minute of pacing, two sets of
arterial and coronary sinus blood samples were drawn with
simultaneous measurements of hemodynamic variables. The
stability of the coronary sinus electrode position during
pacing was confirmed by fluoroscopic control. The presence
of chest pain during pacing and postpacing ST segment
depression were noted.
Analysis of blood samples. Blood samples were trans-
ferred to the laboratory on ice for immediate centrifugation,
and the plasma was decanted and stored at 220°C until
analysis. Plasma ET concentrations were measured by
radioimmunoassay (Nichols Institute, Diagnostic B.V.,
Wichen, The Netherlands). The cross-reactivity of the assay
was 100% with ET-1, 52% with ET-2, 96% for ET-3 and
7% for big ET. Cross-reactivity with atrial natriuretic
peptide, angiotensin II, adrenocorticotropic hormone and
vasopressin was ,0.1%. The interassay variability was
,10%. Lactate concentration was measured in whole blood
as previously described (14).
Statistical analysis. Endothelin data are expressed as
mean 6 SD, and a two-tailed t test was used for pairwise
comparisons between groups. Fractional myocardial sub-
strate extraction (ET and lactate) was calculated as the
arteriocoronary sinus difference divided by the arterial con-
centration and expressed as a percentage. Coronary vascular
resistance was calculated as mean arterial pressure divided by
CSBF (mm Hg/mlzmin21), and from these data the per-
centage fall in coronary vascular resistance during pacing
(%d.CVR) was calculated. This value has two important
advantages: 1) by calculating a statistic for resistance from
the coronary sinus flow rate and mean arterial pressure, the
confounding influence of any change in blood pressure
during pacing is taken into account; and 2) the comparison
of absolute values for coronary sinus flow and CVR calcu-
lated by the thermodilution method is subject to criticism
because these values may be influenced by anatomic factors
and variations in the exact placement of the thermodilution
catheter within the coronary sinus during testing. The
%d.CVR data are presented as median [interquartile range]
in the text; pairwise comparison of %d.CVR data between
groups was performed by the Mann-Whitney U test.
Correlation between %d.CVR and other parameters was
assessed by Pearson’s correlation coefficient. A p value of
less than 0.05 was considered statistically significant. Mul-
tiple regression analysis was performed using a computer
software package (SSPS version 6, SPSS Inc., Chicago,
Illinois).
RESULTS
Baseline characteristics of study groups. The baseline
characteristics of the study group divided according to
gender are presented in Table 1. The proportion of patients
with a positive eECG was higher in the women than in the
men (64% vs. 20%, respectively; p 5 0.14) and exercise test
Abbreviations and Acronyms
CPNA 5 chest pain with normal coronary arteriogram
CSBF 5 coronary sinus blood flow
eECG 5 exercise electrocardiogram
ET 5 endothelin
%d.CVR 5 percentage fall in coronary vascular
resistance during pacing
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duration was also less in women than in men (8.3 6 1.0 vs.
13.6 6 3.0 min, respectively; p 5 0.02).
Immunoreactive ET concentrations. As shown in Table
2, there was no significant difference between baseline
arterial ET concentrations in men and women (1.99 6
0.75 pg/ml vs. 1.67 6 0.58 pg/ml, respectively; p 5 0.36).
Furthermore, there was no significant correlation (R 5
0.14; p 5 0.68) between baseline arterial ET and serum
estradiol concentration in the women. In the study group as
a whole, arterial ET levels did not change significantly
between baseline and pacing (1.76 6 0.63 pg/ml vs. 1.59 6
0.46 pg/ml, respectively; p 5 0.19). No significant differ-
ences in the coronary sinus ET concentrations or ET
extraction were detected between the men and women. Net
lactate extraction was present in both groups at rest and
during pacing, and no significant changes in lactate han-
dling were detected between rest and pacing in either group.
Relationship between ET levels and coronary vasomotor
responses. A strong statistical trend suggested that
%d.CVR was lower in women than men (27[23 to 31]% vs.
34[29 to 45]%—median[interquartile range]; p 5 0.07).
Simple correlation analysis indicated statistical trends sug-
gesting possible correlations between %d.CVR and both
patient gender (R 5 0.35; p 5 0.14) and baseline arterial
ET (R 5 0.41; p 5 0.11). Correlation analysis of the
relationship between %d.CVR and baseline arterial ET
levels in the women alone was even more suggestive that a
significant relationship might exist between these variables
(R2 5 0.34; p 5 0.06). Therefore, backward stepwise
regression analysis was performed including %d.CVR as the
outcome variable and baseline arterial ET concentration,
exercise test positivity, patient gender and age as the initial
predictor variables. After exclusion of exercise test positivity
and patient age (p . 0.6, in both cases), the resulting
multivariate regression model for %d.CVR indicated a
significant relationship (R2 5 0.44; overall p 5 0.02) with
both baseline arterial ET concentration (p 5 0.02) and
patient gender (p 5 0.03) (Fig. 1, Table 3). Although
univariate analysis indicated that the %d.CVR was signifi-
cantly lower in the eECG1 compared with the eECG2
group (27[22 to 29]% vs. 34[29 to 45]%; p 5 0.02), a
relationship between eECG positivity and %d.CVR was not
substantiated by the multivariate regression analysis. This
may have arisen as a result of the confounding influence of
gender and the fact that the baseline arterial ET concentra-
tion was significantly higher in the eECG1 group than the
eECG2 group (2.24 6 0.56 pg/ml vs. 1.40 6 0.40 pg/ml,
respectively; p 5 0.003; see Table 2). There was also no
significant correlation (R 5 0.1; p 5 0.69) between
Table 1. Baseline Characteristics of Study Group
Men (n 5 5) Women (n 5 14) p Value
Age (yr) 47 6 10 55 6 8 0.16
Body mass index (kg/m2) 26.3 6 4.0 24.7 6 4.9 0.49
Total cholesterol (mmol/liter) 6.0 6 1.0 6.5 6 1.2 0.43
Systolic blood pressure (mm Hg) 128 6 9 118 6 9 0.31
Diastolic blood pressure (mm Hg) 74 6 11 74 6 5 0.91
Left ventricular ejection fraction (%) 71 6 4 74 6 8 0.32
Smokers 3 4 0.31*
Exercise test duration (min) 13.6 6 3.0 8.3 6 1.0 0.02
Peak RPP† 307 6 63 308 6 48 0.95
Positive exercise ECG 1 9 0.14*
*Fisher exact test; all other pairwise comparisons performed by unpaired t test. †RPP 5 rate pressure product during exercise test
(31022 mm Hg/min).
ECG 5 electrocardiogram.
Table 2. Immunoreactive Endothelin Concentrations
Men (n 5 5) Women (n 5 14) p* eECG2 (n 5 9) eECG1 (n 5 10) p*
ET1 1.99 6 0.75 1.67 6 0.55 0.36 1.4 6 0.4 2.24 6 0.56 0.003
ET2 1.50 6 0.44 1.63 6 0.49 0.63 1.42 6 0.39 1.72 6 0.49 0.21
ET3 1.64 6 0.53 1.47 6 0.62 0.60 1.41 6 0.6 1.62 6 0.58 0.49
ET4 1.60 6 0.54 1.48 6 0.64 0.72 1.42 6 0.35 1.62 6 0.79 0.54
ET5 12 6 40 10 6 24 0.94 2 6 32 20 6 26 0.25
ET6 28 6 24 8 6 36 0.38 29 6 32 13 6 32 0.22
LAC1 22 6 13 23 6 11 0.93 23 6 14 22 6 9 0.78
LAC2 26 6 11 18 6 8 0.09 20 6 7 21 6 11 0.67
*Unpaired t test.
ET1 5 arterial endothelin concentration at rest (pg/ml); ET2 5 arterial endothelin concentration during pacing (pg/ml); ET3 5 coronary sinus endothelin concentration
at rest (pg/ml); ET4 5 coronary sinus endothelin concentration during pacing (pg/ml); ET5 5 endothelin extraction at rest (%); ET6 5 endothelin extraction during pacing
(%); LAC1 5 lactate extraction at rest (%); LAC2 5 lactate extraction during pacing (%).
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%d.CVR and serum estradiol concentration in the female
patients.
DISCUSSION
Quyyumi et al. (4) have previously demonstrated abnormal-
ities in coronary sinus blood flow responses to both acetyl-
choline and atrial pacing in CPNA patients. They further
demonstrated that there was a strong correlation between
the flow responses observed with the two stimuli and
concluded that microvascular endothelial dysfunction may
contribute to the reduced vasodilator reserve with atrial
pacing in these patients (4). In this study, we used the same
methodology as Quyyumi et al. (4) to assess the relationship
between the coronary vasomotor responses during rapid
atrial pacing and coronary ET concentrations in a CPNA
patient group.
Relationship between gender, baseline arterial ET con-
centration and coronary vascular responses in CPNA
patients. Our findings indicated that both female gender
and baseline arterial ET concentration were independently
predictive of %d.CVR. This inverse relationship is intrigu-
ing, because it predicts that women with high ET levels
would have the lowest %d.CVR during pacing. Our findings
are consistent with those of Huelmos et al. (12), who have
also reported an inverse correlation (R 5 20.59; p , 0.05)
between plasma ET levels and scintigraphically determined
myocardial perfusion reserve in a group of patients with
cardiovascular risk factors. These data further support the
hypothesis that increased ET activity may contribute to
microvascular endothelial dysfunction in CPNA patients.
Our findings regarding female gender must also be consid-
ered in the context that most series of CPNA patients have
been dominated by post- and perimenopausal women
(15,16). The hypothesis that estrogen deficiency is associ-
ated with coronary endothelial dysfunction and abnormal
vasomotor control in such women has been supported by
evidence from a variety of studies (17,18), although the
underlying mechanisms are not clearly understood. How-
ever, in the present study, serum estradiol concentrations
Figure 1. Scattergram illustrating the relationship between base-
line arterial endothelin (ET) concentration and percentage fall in
coronary vascular resistance during rapid atrial pacing in men and
women; dashed lines represent simple regression plots for women
(circles) (R2 5 0.34; p 5 0.06) and men (squares) (R2 5 0.62;
p 5 0.11).
Table 3. Arterial Endothelin Concentrations and Coronary Vasomotor Responses During Rapid Atrial Pacing
Patients* Gender eECG ET1
Rest Pace
%d.CVRCSBF MAP CVR CSBF MAP CVR
1 F 1 2.07 133 79 0.6 158 92 0.58 23%
2 F 1 2.62 114 99 0.87 132 111 0.84 23%
3 F 1 † 185 98 0.6 231 105 0.47 222%
4 F 1 2.37 101 112 1.11 142 123 0.86 223%
5 F 2 0.66 111 102 0.92 153 107 0.7 224%
6 F 2 1.19 71 123 1.73 107 140 1.31 224%
7 F 1 1.92 134 94 0.71 175 90 0.52 227%
8 F 1 1.59 119 99 0.85 171 106 0.62 227%
9 F 1 † 102 91 0.91 143 94 0.65 229%
10 M 1 3.26 83 105 1.26 109 97 0.89 229%
11 F 2 1.56 148 81 0.75 196 90 0.52 231%
12 F 1 1.87 110 94 0.86 181 105 0.59 231%
13 M 2 1.62 110 96 0.89 161 95 0.59 234%
14 M 2 2.09 76 96 1.27 116 98 0.84 234%
15 M 2 1.49 105 91 0.87 204 104 0.51 241%
16 F 1 † 119 106 0.9 225 113 0.5 244%
17 F 2 1.09 100 88 0.88 171 81 0.48 245%
18 M 2 1.49 72 101 1.41 143 112 0.76 246%
19 F 2 1.38 69 100 1.41 84 89 0.75 247%
*Patients listed in ascending order of percentage change in coronary vascular resistance between rest and pacing (%d.CVR). †Blood sample inadequate for analysis.
CSBG 5 coronary sinus blood flow (ml/min); CVR 5 coronary vascular resistance (mm Hg/mlzmin21); eECG 5 exercise electrocardiogram (1 5 positive, 2 5 negative);
ET1 5 baseline arterial endothelin concentration (pg/ml); F 5 female; M 5 male; MAP 5 mean arterial blood pressure (mm Hg).
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did not correlate with either plasma ET concentration or
%d.CVR in the female patients; therefore, this sole factor
cannot explain the observed differences.
Pathophysiologic significance of ET in CPNA patients.
Endogenous production of ET, a potent vasoconstrictor
peptide (7), contributes to the balanced opposition between
vasodilator and vasoconstrictor mediators involved in endo-
thelial regulation of vascular tone (6–8). Therefore, it seems
reasonable to speculate that increased levels of a potent
vasoconstrictor peptide such as ET in certain patients might
contribute to reduced vasodilatory responses, and the data
presented in our study support the existence of such a
relationship. Nonetheless, a similar relationship between
%d.CVR and either the arterial ET concentration during
pacing or the net ET balance (extraction or production)
across the coronary circulation might have provided more
compelling evidence in this context. However, one must
remember that ET produced by the vascular endothelium
functions primarily as a paracrine mediator, with up to 75%
of ET from cultured endothelial cells being secreted in the
abluminal direction, that is, toward the vascular smooth
muscle cells (19). The mechanisms responsible for and
controlling ET extraction across the coronary vascular bed
are also not well understood. Consequently, variations in
local endothelial ET production and effects on vascular
smooth muscle may not be reflected in a simple relationship
by changes in plasma ET concentrations. Therefore, we do
not believe that these data can be discounted simply because
they do not conform to a simple model. The consistency of
our observations with recent findings by Huelmos et al. (12)
and Newby et al. (11) supports this view.
The relationship between endothelial microvascular dys-
function, coronary flow abnormalities and myocardial
ischemia in CPNA patients. The relationship between
endothelial microvascular dysfunction, coronary flow abnor-
malities and myocardial ischemia in CPNA patients re-
mains uncertain (20). A high incidence of scintigraphic
perfusion defects has been reported in CPNA patients
(21,22), and an association between scintigraphic perfusion
defects and impaired regional endothelium-dependent va-
sodilation of the coronary microcirculation has now also
been demonstrated in this group (23,24). Such perfusion
abnormalities may be attributed to inhomogeneity of blood
flow between different myocardial regions without absolute
reductions in blood flow (20). In this context, Meeder et al.
(25) have demonstrated increased heterogeneity of myocar-
dial perfusion in CPNA patients compared with healthy
volunteers using positron emission tomography. Maseri et
al. (26) have proposed that “patchy” constriction of preart-
eriolar vessels due to increased sympathetic tone or focal
release of vasoactive mediators in CPNA patients may lead
to heterogeneity of blood flow and small ischemic foci. The
existence of an ischemic mechanism has also been supported
by recent preliminary findings indicating the presence of
increased intracardiac oxidative stress in CPNA patients
(27). Animal studies (28) have also suggested that ET may
have algogenic properties and, consequently, elevated ET
levels in CPNA patients might contribute to both the
evolution of an ischemic stimulus and its “amplification”
through an algogenic mechanism (29).
Increased coronary sinus lactate concentrations during
pacing stress have been demonstrated in CPNA patients in
some studies (3,30,31), but others (30,32) which excluded
patients with hypertension and left bundle branch block
have failed to demonstrate lactate production during pacing
stress in similar patient groups. However, the absence of
lactate production as in the present study does not neces-
sarily exclude an ischemic mechanism, because lactate ex-
change may be an insensitive marker of myocardial isch-
emia. This assertion is supported by the results of other
studies (33) which have failed to detect lactate production
during stress in patients with significant macrovascular
coronary stenoses. It is also possible that lactate efflux from
small areas of focal ischemia in CPNA patients may be
obscured due to dilution by blood draining from neighbor-
ing, normally perfused areas. Even in the absence of lactate
production, significant differences in the pattern of myocar-
dial substrate metabolism during atrial pacing have been
reported in CPNA patients (22).
Conclusions. The data presented in this study lend further
support to the hypothesis that increased ET activity may be
associated with coronary microvascular dysfunction in
CPNA patients.
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